Recent research studies funded by PSC Support:
December 2019: The development of a diagnostic blood test for PSC (£10,000)
October 2019: PSC600: A UK-PSC Initiative (£20,000)
September 2019: Early detection of bile duct cancer (£45,000)
July 2018: The PSC Wellbeing Study Psychological Intervention for PSC (£40,000)
January 2018: Quality of Life in people with PSC (£50,000)
January 2018: Single cell transcript analysis of liver infiltrating lymphocytes in primary sclerosing cholangitis by fine needle aspiration of the liver (£20,000)
December 2017: Validating the Prognostic Utility of Vascular Adhesion Protein 1 in Primary ScleRosing Cholangitis: The VAPoR Study (£15,000)
August 2017: Deriving T cell gene-expression signatures of primary sclerosing cholangitis (£24,480)
June 2016: Investigation of the effect of male cholestasis on the epigenome of sperm and the impact on the health of children of men with cholestasis (£25,000)
June 2016: An unbiased screen for novel clinical and molecular biomarkers of the progression of primary sclerosing cholangitis to biliary tract cancer (£7,000)
October 2015: West Midlands Virtual PSC Programme (£10,000)
May 2015: The role of non-canonical Wnt signalling in the establishment of fibrosis during PSC (£18,106.13)
October 2014: UK-PSC Project Manager (£15,125)